کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
8322542 | 1539877 | 2015 | 9 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis
ترجمه فارسی عنوان
مکانیزم های اپیگنتیک: یک نقش در حال ظهور در پاتوژنز و پتانسیل درمانی آن در بیماری اسکلروز سیستمیک
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
FBSTGF-βFli1platelet/endothelial cell adhesion moleculeCCN2S1P1DNA methyltransferasesPECAMDNMTsCXCL5PDGFmethyl-CpG-binding domainMBDSMRSRCHDACsCTGFSAMPAHmiRNAsTETSSC5mC - 5 سانتی متر5-Methylcytosine - 5-متیل سیتوزینS-adenosyl-methionine - S-آدنوزیل-متیونینsystemic sclerosis - اسکلروز سیستمیکScleroderma renal crisis - بحران کلیوی اسکلرودرمیDizygotic - بیضویTransforming Growth Factor Beta - تبدیل بتا فاکتور رشدmicroRNAs - ریز آرانایMicrovascular endothelial cells - سلولهای اندوتلیال میکروواسکولارTranscription factor - عامل رونویسیConnective tissue growth factor - فاکتور رشد بافت همبندplatelet derived growth factor - فاکتور رشد حاصل از پلاکتPulmonary arterial hypertension - فشار خون شریانی ریویFibroblasts - فیبروبلاست هاJAMs - مرباجاتjunctional adhesion molecules - مولکول های چسبندگی مجاورMonozygotic - مونوزیگوتstandardized mortality ratio - نسبت مرگ و میر استاندارد شدهhistone deacetylases - هیستون deacetylaseshistone acetyltransferases - هیستون استیل ترانسفرازHATs - کلاه
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
زیست شیمی
چکیده انگلیسی
Systemic sclerosis (SSc) is a heterogeneous and life-threatening autoimmune disease characterized by damage to small blood vessels, interruption of immune homeostasis and ultimately, fibrosis. Currently, the mechanisms involved in SSc pathogenesis remain unknown. An increasing amount of data shows that, via certain signaling pathways, epigenetic mechanisms, including DNA methylation, histone modification, and miRNAs, are closely related to the three primary processes that characterize SSc: vascular abnormalities, activation of immune system, and excessive extracellular matrix deposition. In the clinical setting, identification of molecules and biomarkers for determining disease severity, predicting disease progression and assessing response to treatment remains challenging. In this review, we aim to summarize the key epigenetic mechanisms involved in the pathogenesis of SSc. Certain cytokines or molecules, such as CD40, CD70, and Fli-1, are expressed at varying rates in SSc due to epigenetic modification and play important roles in SSc. It is therefore likely that these molecules may be biomarkers for SSc. In addition, epigenetic changes of certain genes, including Fli-1, BMPRII, CD11a, Foxp3, and eNOS, influence the expression of these genes to ultimately result in an anti-fibrotic effect. The influence that epigenetics has on SSc pathogenesis suggests that epigenetics-targeting drugs may have potential therapeutic effects against SSc. This article is part of a Directed Issue entitled: Epigenetics dynamics in development and disease.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: The International Journal of Biochemistry & Cell Biology - Volume 67, October 2015, Pages 92-100
Journal: The International Journal of Biochemistry & Cell Biology - Volume 67, October 2015, Pages 92-100
نویسندگان
Yangyang Luo, Yong Wang, Ye Shu, Qianjin Lu, Rong Xiao,